Towards precision medicine in heart failure.

Nature Reviews. Cardiology
Chad S Weldy, Euan A Ashley

Abstract

The number of therapies for heart failure (HF) with reduced ejection fraction has nearly doubled in the past decade. In addition, new therapies for HF caused by hypertrophic and infiltrative disease are emerging rapidly. Indeed, we are on the verge of a new era in HF in which insights into the biology of myocardial disease can be matched to an understanding of the genetic predisposition in an individual patient to inform precision approaches to therapy. In this Review, we summarize the biology of HF, emphasizing the causal relationships between genetic contributors and traditional structure-based remodelling outcomes, and highlight the mechanisms of action of traditional and novel therapeutics. We discuss the latest advances in our understanding of both the Mendelian genetics of cardiomyopathy and the complex genetics of the clinical syndrome presenting as HF. In the phenotypic domain, we discuss applications of machine learning for the subcategorization of HF in ways that might inform rational prescribing of medications. We aim to bridge the gap between the biology of the failing heart, its diverse clinical presentations and the range of medications that we can now use to treat it. We present a roadmap for the future of precis...Continue Reading

References

Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Apr 23, 1999·The Journal of Biological Chemistry·D A MasonS B Liggett
Nov 25, 2000·Circulation Research·S E LitwinJ H Bridge
Jun 21, 2001·JAMA : the Journal of the American Medical Association·R SchiffmannR O Brady
Jul 7, 2001·The New England Journal of Medicine·C M EngUNKNOWN International Collaborative Fabry Disease Study Group
Jan 24, 2002·Nature·Donald M Bers
Jan 24, 2002·Nature·Howard A RockmanRobert J Lefkowitz
Feb 20, 2002·JAMA : the Journal of the American Medical Association·JoAnne Micale FoodyHarlan M Krumholz
Jul 11, 2002·Journal of the American College of Cardiology·Víctor G Dávila-RománRobert J Gropler
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Sep 27, 1962·The New England Journal of Medicine·C A CHIDSEYE BRAUNWALD
Sep 1, 1965·The American Journal of Medicine·C A CHIDSEYA G MORROW
Sep 25, 2003·Physiological Reviews·Antoon F M Moorman, Vincent M Christoffels
Nov 3, 2004·Nature Reviews. Genetics·Choong-Chin Liew, Victor J Dzau
Nov 10, 2004·The New England Journal of Medicine·Anne L TaylorUNKNOWN African-American Heart Failure Trial Investigators
Jul 1, 2005·Physiological Reviews·William C StanleyGary D Lopaschuk
Jul 15, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Daniel BurkhoffHiroyuki Suga
Oct 1, 2005·Circulation Research·Thomas MünzelAlexander Mülsch
Nov 24, 2005·Nature Reviews. Genetics·Margaret BuckinghamStéphane Zaffran
Jan 1, 1937·The Journal of Clinical Investigation·S WeissF W Haynes
Jun 3, 2006·The Journal of Clinical Investigation·Cinzia PerrinoHoward A Rockman
Jul 14, 2006·The New England Journal of Medicine·Douglas S LeeRamachandran S Vasan
Jul 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stephen B LiggettMichael R Bristow
Sep 7, 2006·Nature Reviews. Drug Discovery·Oleg V EvgenovJohannes-Peter Stasch
Jan 12, 1927·The Journal of Physiology·E H Starling, M B Visscher
Nov 10, 2006·The New England Journal of Medicine·Ferid Murad
Mar 1, 2007·JAMA : the Journal of the American Medical Association·Goran BjelakovicChristian Gluud
Mar 6, 2007·Developmental Cell·Joaquín Grego-BessaJosé Luis de la Pompa
Mar 16, 2007·The New England Journal of Medicine·Stefan Neubauer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.